Citius pharmaceuticals to present at the h.c. wainwright global investment conference on may 24, 2022

Cranford, n.j. , may 18, 2022 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today announced that it will present at the h.c.

CTXR Ratings Summary

CTXR Quant Ranking